IOF - International Osteoporosis Foundation

Left Navigation
About IOF Vision, Mission, Goals Board & Executive Committee Committee of Scientific Advisors Committee of National Societies Committee of Corporate Advisors Staff Annual Report

IOF extends a warm welcome to Bank Hofmann AG, Prous Science and Torre Lazur-McCann. These new CCA members are the first from the financial, publishing and advertising sectors.

Read more

Top Navigation Homepage Search Sitemap Contact IOF Members Only

Committee of Corporate Advisors

Yannis Tsouderos, Chairman Chairman of the CCA
Yannis Tsouderos

Marcel Lechanteur, Vice-Chairman Vice-Chairman of the CCA
Marcel Lechanteur

The Committee of Corporate Advisors (CCA) is composed of many different types of corporations, the majority in the fields of healthcare and consumer products. Since some of today's most significant osteoporosis research and development work is being undertaken within the corporate arena, this community plays a vital role in our battle to prevent and treat osteoporosis. The Committee of Corporate Advisors gives representation within IOF to this important group. Member companies pay a one-time entry fee and yearly dues. The Committee meets twice a year. Annual membership dues of the Committee of Corporate Advisors and additional funds raised by the members are put toward the general operation and programme costs of IOF.

The chairman of the CCA for the term commencing November 2002 is Yannis Tsouderos (France) and the vice chairman is Marcel Lechanteur (USA).

IOF welcomes applications from corporations wishing to contribute to prevention, diagnosis and treatment of osteoporosis to join CCA, and enjoy numerous membership benefits.

Members of the Committee – July 2005

Abiogen Pharma Spa
Asahi Kasei Pharma Corporation
Bank Hofmann AG
Eisai Co., Ltd.
Eli Lilly and Co
F. Hoffman-LaRoche Ltd.
Fonterra Brands
GE Medical Systems LUNAR
Hologic Europe NV
Iris (Servier)
Kyphon US
Meda Pharma GmbH
Merck Sharp & Dohme
Nestlé Suisse SA
Nordic Bioscience Diagnostics A/S
Novartis Pharmaceuticals
NPS Pharmaceuticals Inc.
Nycomed Pharma AG
Organon International Inc.
Pfizer Global Pharmaceuticals
Procter & Gamble Pharmaceuticals
Rottapharm S.p.a.
Sangemini S.P.A.
sanofi aventis
Schering A.G.
Teijin Pharma Limited
Tetra Pak
Teva Pharmaceutical Industries Ltd
Torre Lazur-McCann Erickson
Weber Shandwick
Wyeth Pharmaceuticals

Page Top

Homepage | Search | Sitemap | Contact IOF | Members Only

© 2005 International Osteoporosis Foundation:
About IOF | Legal Disclaimer